anmelden
Novo Nordisk Aktie
44,69
EUR
-0,19
EUR
-0,41
%
44,75
EUR
-0,24
EUR
-0,52
%
Novo Nordisk jetzt ohne Ordergebühren (zzgl. Spreads) handeln beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)
Werbung
Novo Nordisk Aktie Analyse
| 24.02.16 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
| 22.02.16 | Novo Nordisk Hold | Jefferies & Company Inc. | |
| 16.02.16 | Novo Nordisk Neutral | BNP PARIBAS | |
| 15.02.16 | Novo Nordisk Conviction Buy List | Goldman Sachs Group Inc. | |
| 09.02.16 | Novo Nordisk Halten | Independent Research GmbH | |
| 08.02.16 | Novo Nordisk Sell | UBS AG | |
| 04.02.16 | Novo Nordisk overweight | Barclays Capital | |
| 04.02.16 | Novo Nordisk Neutral | UBS AG | |
|
Werbung
|
|||
| 04.02.16 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
| 03.02.16 | Novo Nordisk verkaufen | S&P Capital IQ | |
| 01.02.16 | Novo Nordisk buy | Goldman Sachs Group Inc. | |
| 01.02.16 | Novo Nordisk buy | Citigroup Corp. | |
| 01.02.16 | Novo Nordisk overweight | Morgan Stanley | |
| 01.02.16 | Novo Nordisk Neutral | UBS AG | |
| 01.02.16 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
| 26.01.16 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
| 21.01.16 | Novo Nordisk buy | Goldman Sachs Group Inc. | |
| 14.01.16 | Novo Nordisk Hold | Jefferies & Company Inc. | |
| 08.01.16 | Novo Nordisk overweight | Barclays Capital | |
| 07.01.16 | Novo Nordisk buy | Goldman Sachs Group Inc. | |
| 06.01.16 | Novo Nordisk overweight | Morgan Stanley | |
| 10.12.15 | Novo Nordisk Neutral | BNP PARIBAS | |
| 02.12.15 | Novo Nordisk overweight | Morgan Stanley | |
| 01.12.15 | Novo Nordisk Halten | Independent Research GmbH | |
| 30.11.15 | Novo Nordisk Hold | Deutsche Bank AG | |
| 25.11.15 | Novo Nordisk buy | Goldman Sachs Group Inc. | |
| 20.11.15 | Novo Nordisk Neutral | UBS AG | |
| 20.11.15 | Novo Nordisk buy | Citigroup Corp. | |
| 20.11.15 | Novo Nordisk buy | Goldman Sachs Group Inc. | |
| 20.11.15 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
| 19.11.15 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
| 17.11.15 | Novo Nordisk buy | Goldman Sachs Group Inc. | |
| 05.11.15 | Novo Nordisk Hold | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 03.11.15 | Novo Nordisk buy | Citigroup Corp. | |
| 02.11.15 | Novo Nordisk Hold | Jefferies & Company Inc. | |
| 30.10.15 | Novo Nordisk overweight | Morgan Stanley | |
| 30.10.15 | Novo Nordisk Reduce | HSBC | |
| 29.10.15 | Novo Nordisk verkaufen | S&P Capital IQ | |
| 29.10.15 | Novo Nordisk buy | Citigroup Corp. | |
| 26.10.15 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
| 21.10.15 | Novo Nordisk buy | Goldman Sachs Group Inc. | |
| 19.10.15 | Novo Nordisk Neutral | UBS AG | |
| 15.10.15 | Novo Nordisk Neutral | UBS AG | |
| 15.10.15 | Novo Nordisk Hold | Commerzbank AG | |
| 28.09.15 | Novo Nordisk buy | Citigroup Corp. | |
| 28.09.15 | Novo Nordisk overweight | Morgan Stanley | |
| 28.09.15 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
| 28.09.15 | Novo Nordisk Neutral | UBS AG | |
| 28.09.15 | Novo Nordisk buy | Goldman Sachs Group Inc. | |
| 24.09.15 | Novo Nordisk Reduce | HSBC | |
Werbung
Werbung